Home > Boards > US Listed > Miscellaneous >

Diffusion Pharmaceuticals Inc. (DFFN)

DFFN RSS Feed
Add DFFN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/24/2019 2:38:28 PM - Followers: 32 - Board type: Free - Posts Today: 0

Diffusion Pharma files for $50M mixed shelf offering. May 16, 2019 4:50 PM ET. A mixed shelf offering is the ability to offer securities for sale with different size, price and terms which may be determined at the time of  sale. 
http://www.investorwords.com/11701/mixed_shelf.html#ixzz5oac7cWcF   


The biggest obstacle that the company faced was the lack of funds. That has now been resolved. The company will do very good things with the new funds. 

This expected new capital will fund the advancement of lead candidate trans sodium crocetinate (TSC) for the treatment of stroke and cancer.


Diffusion Pharmaceuticals is an absolute homerun once their products comer to market. We are talking a Google-like price tag. They offer an exciting new approach to the treatment of life-threatening diseases where cellular oxygen deprivation (known as “hypoxia”) is a key factor. This lack of oxygen is given different names, usually linked to the location of the oxygen deficiency.

Oxygen deprivation in the brain is a stroke; in the heart it’s a heart attack; in the legs, it’s peripheral arterial disease; systemically it may be respiratory.  Lack of oxygen in a cancerous tumor causes something called treatment resistance.  But wherever it is located and whatever it is called, the lack of oxygen in the human body carries severe consequences which may quickly become deadly.

Diffusion Pharmaceuticals is an absolute homerun once their products comer to market. We are talking a Google like price tag. They offer an exciting new approach to the treatment of those life-threatening diseases where cellular oxygen deprivation (known as “hypoxia”) is a key factor. This lack of oxygen is given different names, usually linked to the location of the oxygen deficiency.

Oxygen deprivation in the brain is a stroke; in the heart it’s a heart attack; in the legs, it’s peripheral arterial disease; systemically it may be respiratory.  Lack of oxygen in a cancerous tumor causes something called treatment resistance.  But wherever it is located and whatever it is called, the lack of oxygen in the human body carries severe consequences which may quickly become deadly.

 

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy.

       The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC) is used in various cancer types, in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments.
                               The Company's Diffusion's technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate, TSC, with standard-of-care radiation and chemotherapy regimens, thus effecting a better patient survival outcome without the addition of harmful side effects.
Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types, with an initial focus on primary brain cancer (glioblastoma or GBM), pancreatic cancer, and brain metastases.




ABOUT

Diffusion Pharmaceuticals is a Phase 3 clinical-stage biotech company dedicated to improving the outcome for cancer patients, stroke victims and others afflicted with life-threatening disease where cellular oxygen deprivation (known as ``hypoxia``) is a key factor

 

TECHNOLOGY

Our lead drug, Trans Sodium Crocetinate (“TSC”), targets the oxygen-deprived micro-environment of affected tissue, restoring life-giving oxygen to ischemic cells in stroke making cancer cells more vulnerable to the cancer-killing power of radiation and chemotherapy

 

INDICATIONS

Clinical targets include cancer, where a phase 3 trial in inoperable GBM brain cancer is enrolling patients, and acute ischemic stroke where we have received FDA approval for an innovative phase 2 protocol allowing in-ambulance administration of TSC

 
                                                                      
  • Avg Vol (10-day): 41.0K
    52-Wk Range: 1.83 - 11.00
    Market Cap: 19.9M

                                                                                   
 

 

   .

 

DFFN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2704   Hmmmmmmmmmmm, I have a feeling this is going MadHatter326 05/24/19 02:38:28 PM
#2703   I jumped in today $3.75...paying a buck less bUrRpPPP! 05/24/19 11:57:51 AM
#2702   Don't understand the 20% drop in premarket trading rawsteel 05/24/19 09:24:21 AM
#2701   So private institutional investors paying market price ... staccani 05/24/19 09:20:22 AM
#2700   Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct rawsteel 05/24/19 09:20:21 AM
#2699   1. They filed for a mized shelf offering staccani 05/23/19 03:25:12 PM
#2698   Guess that was what the run up the rawsteel 05/23/19 10:32:31 AM
#2697   Diffusion Pharmaceuticals Receives Notice of Intention to Grant rawsteel 05/23/19 09:27:20 AM
#2696   They have the funding. boston127 05/22/19 02:55:40 AM
#2695   Occasionally, I get the facts right. boston127 05/22/19 01:54:31 AM
#2694   Good work and YES maverick_1 05/21/19 10:05:59 PM
#2693   Mixed shelf offering: good or bad. boston127 05/21/19 03:45:52 PM
#2692   Diffusion Pharma files for $50M mixed shelf; shares maverick_1 05/16/19 08:34:39 PM
#2691   Ready to head out this range? Awl416 05/16/19 11:24:34 AM
#2690   Feeling antsy today Awl416 05/16/19 08:32:00 AM
#2689   Volume volume volume Awl416 05/15/19 02:44:51 PM
#2688   Ahhhh shiettt is it time again? :-D $DFFN CaptainWeee 05/15/19 07:49:40 AM
#2687   Thank you bro! I have my eyes on 99Lexus 05/15/19 07:05:25 AM
#2686   Bout time to keep an eye on $dffn 99Lexus 05/15/19 07:04:51 AM
#2685   AND ITS ONLY TUESDAY LMFAO CamelotSR 05/14/19 10:37:47 PM
#2684   4.00 to 4.64 today and it’s only Tuesday. CamelotSR 05/14/19 10:37:12 PM
#2683   4.00 to 4.64 today and it’s only Tuesday. CamelotSR 05/14/19 10:36:18 PM
#2682   Still waiting... Awl416 05/14/19 10:31:42 PM
#2681   Big move coming mid week CamelotSR 05/10/19 05:11:05 PM
#2680   From ph2GBM trial ' The tumors staccani 05/10/19 01:32:56 AM
#2679   From 10Q' Commencement of the randomization portion of staccani 05/09/19 05:19:18 PM
#2678   Looks like they are banking all on first staccani 05/09/19 04:58:39 PM
#2677   Something does not add up. staccani 05/09/19 11:06:18 AM
#2676   GOLDEN CROSS COMING !!!! YEAH BABY!! CamelotSR 05/08/19 04:33:01 PM
#2675   Please in the attched link ph2 GBM study staccani 05/05/19 01:56:14 PM
#2674   Question for the board. Do we know ho staccani 05/05/19 06:59:47 AM
#2673   I agree with you. boston127 05/03/19 11:43:39 PM
#2672   Money can and will be found if TSC staccani 05/03/19 02:35:12 PM
#2671   Wouldn't have thought this if I hadn't checked rawsteel 05/03/19 02:09:53 PM
#2670   They have no money. boston127 05/03/19 12:59:12 PM
#2669   Can please somebody explain me how it's possible staccani 05/03/19 11:13:18 AM
#2668   Held it close to $4.50, let's break 5. rawsteel 05/03/19 09:50:00 AM
#2667   Haha my guy!!! $DFFN CaptainWeee 05/03/19 09:42:44 AM
#2666   I'm still pulling for the Bulls and not rawsteel 05/03/19 09:41:04 AM
#2665   Dandy Don Meredith would say: Turn out the rawsteel 05/03/19 09:39:18 AM
#2664   I was hoping for a better scenario but rawsteel 05/03/19 09:18:15 AM
#2663   Selloff is surprising. boston127 05/03/19 09:11:18 AM
#2661   Premarket DUMPING Disquisition 05/03/19 08:22:28 AM
#2660   Selling off in premarket. Hopefully that is just rawsteel 05/03/19 07:10:21 AM
#2659   Nice catch! homeboy4u 05/03/19 06:27:45 AM
#2658   Bro was riding 2.80’s i picked up the 99Lexus 05/03/19 02:14:57 AM
#2657   No truth to that rumor. boston127 05/03/19 12:08:49 AM
#2656   PT: $36, Successful Phase 3 results for INTACT rezivor321 05/02/19 08:45:56 PM
#2655   2009 was 39,000 dollars and 2012 was 9,000 dinogreeves 05/02/19 08:24:50 PM
#2654   Lol, I never watch them as stock manipulation easymoney 05/02/19 08:10:53 PM
PostSubject